Open AccessProspects for Minimal Residual Disease as a Surrogate Endpoint in Pediatric Acute Lymphoblastic Leukemia Clinical Trials
Author(s) -
Lisa M. McShane,
Malcolm A. Smith
Publication year - 2018
Publication title -
jnci cancer spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.345
H-Index - 10
ISSN - 2515-5091
DOI - 10.1093/jncics/pky070
Subject(s) - medicine , minimal residual disease , lymphoblastic leukemia , surrogate endpoint , clinical trial , intensive care medicine , clinical endpoint , endpoint determination , residual , disease , pediatrics , oncology , leukemia , algorithm , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom